---
schema_version: "secwatch.filing_event.v1"
accession: "0001477932-25-005422"
form_type: "8-K"
ticker: "VNRX"
cik: "0000093314"
company_name: "VOLITIONRX LTD"
filed_at: "2025-08-04T23:59:59+00:00"
generated_at: "2026-05-17T21:43:11.057258+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# VolitionRx raises $1.21M in registered direct offering; insiders buy stock

## Summary
- 156,250 shares sold to directors/officers at $0.64/share; 1,734,375 shares + warrants at $0.64/unit.
- Gross proceeds of $1.21M; potential additional $1.3M from warrants at $0.768/share.
- Warrants exercisable for 5 years from Aug 2025; insiders receive no warrants.
- No placement agent; offering expected to close Aug 5, 2025.
- Net proceeds for R&D, product development, clinical studies, working capital, and potential M&A.

## SEC filing metadata
- accession: 0001477932-25-005422
- form_type: 8-K
- ticker: VNRX
- cik: 0000093314
- company_name: VOLITIONRX LTD
- filed_at: 2025-08-04T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 1.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/93314/000147793225005422/0001477932-25-005422-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/93314/000147793225005422/vnrx_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001477932-25-005422
- JSON: https://secwatch.observer/filing/0001477932-25-005422.json
- Plain text: https://secwatch.observer/filing/0001477932-25-005422.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.